Dr. Gregory Cheng says patients with chronic idiopathic thrombocytopenia purpura are more likely to achieve target platelet counts when treated with oral eltrombopag. Jane MacNeil of Elsevier Global Medical News (EGMN) reports from the annual meeting of the American Society of Hematology.